Catalyst Wire Dossier Catalyst Wire Dossier

Autologous invariant natural killer cells

Invariant natural killer cells (iNKT) · Beth Israel Deaconess Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous invariant natural killer cells, covering 2017-06-09 to 2017-06-09. Get the full timeline:

Most recent: Clinical Trial Update: In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer [Phase 1]

See pricing